Asia

Haleon Completes Deal To Grow Stake In China JV

 
• By 

Haleon now holds 88% of its China OTC joint venture after acquiring a larger stake in the business from its local partners.

APAC Congress: Regulators And Industry Agree ‘Bangkok Joint Initiative on Self-Care’

 
• By 

Organizations representing APAC health and medicines regulators and the consumer health industry respectively have agreed to “recognize the importance of self-care as a fundamental pillar of health and wellbeing” and “affirm our dedication to advancing self-care as an essential component of Universal Health Coverage.”

APAC Self-Care Congress: ‘Human Health Without Environmental Health Is Just Not Possible’

 
• By 

Self-care industry representatives from GSCF/AESGP, Bayer and Opella stress the seriousness of the global climate crisis at the 2024 GSCF, APSMI, TSMIA Joint Congress in Bangkok, Thailand, and also share iniatives that are attempting to deal with this crisis, for example replacing PVC in medicine blister packs with more easily recyclable materials.

Self-Care Policies Could Save Asia Pacific More Than $50bn A Year In Health Costs

 
• By 

GSCF research shows that self-care already saves the Asia Pacific region more than $30bn a year in healthcare system costs. To realize higher gains, health literacy, Rx-to-OTC switch and digitalization need to be leveraged, according to the EU-ASEAN Business Council.


Self-Care ‘Essential’ To Universal Health Coverage, Stress Asia Pacific Health Agencies

 
• By 

APAC health agencies such as WHO and Thailand's FDA are on board with the self-care agenda, and see it as crucial to achieving universal health coverage.

People On The Move: Appointments At PharmaSGP, Stada, NèreS

 
• By 

A round-up of recent consumer health appointments: PharmaSGP names new CEO; Stada appoints Vietnam head; NèreS adds to board.

Haleon Talks Up China Strength As Investment Grows

 
• By 

Haleon highlighted consistent market share gains in China as it reported third-quarter results.

Haleon Strengthens Control Of China JV, Agrees Option To Buy

 
• By 

Joint venture business which markets Haleon's OTC drug brands in China will soon be 88% owned by the UK-based firm.


P&G On SK-II Struggles In China: ‘We’re Ready To Come Back’

 

P&G has worked to ‘rebuild’ the SK-II brand in China over the past year with a focus on product quality, efficacy and the line’s core ingredient, as well as improved messaging, and recently launched SK-II's ‘most crafted, exclusive and luxurious skin care series’ to date, CFO Andre Schulten noted at the Barclays Global Consumer Staples Conference.

Brushing Up For Oral Care Market Share, US Startups Launch Brushes, Toothpastes, Whiteners

 

Laifen, Opalescence Moon, Lewie and quip are among US companies with recent launches to boost their oral care market shares. Recent launch by Arm & Hammer global oral care brand also targets driving growth in the category.

Stada Expands In MENA And APAC As Emerging Markets Strategy Pays Dividends

 
• By 

Germany's Stada Arzneimittel has secured the rights to market the FITO self-care medical device in the Gulf Cooperation Council region, North Africa, the Middle East and selected Asian Countries, and the Nizoral antifungal cream in Vietnam, the Philippines and Thailand. Stada’s half-year results show that the company’s emerging markets strategy is delivering results, with  MENA and APAC contributing to the growth recorded by the Consumer Healthcare division.

People On The Move: Appointments At Nestlé, Ascendis Health, Be-sup

 
• By 

A round-up of the latest global health and wellness moves: Nestlé and Dr Reddy's name JV head; Be-sup hires comms and regulatory director; Ascendis Health appoints interim CFO.


Oxy Marks 50th Anniversary With Line Extensions, Redesigned Packages And Acne Renamed ‘Ne’

 

Mentholatum says two line extensions made with 2% salicylic acid and its "Oxy for Every Kind of Ne" campaign reinforce the brand’s “commitment to tackling every type of acne—from face-ne and chin-ne to body-ne.”

Check Contract Manufacturers' GMP Compliance, US FDA Warns Eye Drop Firm, Lip Balm Provider

 

Request to recall eye drops should be fulfilled promptly and businesses providing lip balms as promotional products must verify contract manufacturers are compliant, recent FDA warnings states. Additional letters went to Jordanian firm about testing alcohol for methane and to a Chinese firm advised that compliance with China’s quality control standards isn’t sufficient.

People On The Move: Appointments At Bayer, Haleon, Bionorica

 
• By 

Round-up of the latest appointments in the health and wellness markets outside the US: Bayer names joint LATAM/APAC president; Haleon adds directors to board; Bionorica hires global marketing head.

Kenvue Increases Marketing Spend To Boost Consumer Loyalty, Expand Reach To More

 

Kenvue maintains full-year guidance after 0.3% Q2 net sales dip beat market expectations. Essential health segment alone drove sales; self-care and skin health/beauty faltered. US sales of Neutrogena Collagen Bank pre-aging platform launched on TikTok shop, a first for the brand.


L’Oréal’s ‘Robust’ European Sales Offset US Slowdown, Continued Weakness In China

 

L’Oréal's European business recorded sales growth of 9.7% to €3.55bn in the second quarter as consumer confidence grows, while in the US sales slowed for the dermatological beauty business and consumers in China are value-shopping.

EL Companies CFO; L'Oreal Skinceuticals Expanding In Japan; And More, Personal Care News Briefs

 

Estee Lauder Companies taps a CFO; L’Oréal SA expands SkinCeuticals brand in Japan through Cutera partnership; IFF's Shanghai Creative Center operational by September; vegan hair care brand Naturaz expanding retail with seed funding; American Exchange Group acquires Indie Lee; and US men using skin care up 68% since 2022.  

Lingering Headwinds Slow Latest Results, But P&G Rebuffs Concerns About Consumer Spending

 

P&G's FY2024 Q4 net sales were flat at $20.5bn, lower than consensus estimates, but the firm says its underlying business divisions are healthy and forecasts FY2025 sales up 2% to 4%, up 3% to 5% organically.

Unilever Plans To Launch As Many As 12 'Bigger And Better' Innovations Starting In 2025

 

Unilever hopes to double the value of its product innovations this year, ultimately targeting as many as 12 innovations, each costing more than €100m, beginning in 2025, CEO Hein Schumacher says during 25 July earnings presentation.